The Global patient support program market size was valued at $xx Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Bn in 2030. Factors driving this market include an aging population, the increasing prevalence of chronic diseases, and the rising cost of healthcare. The market is segmented by delivery type, component type, and therapeutic area, application type, end-user type. Some of the key players in the global patient support program market include Pfizer, Novartis, Roche, and Merck.

1. Global Patient
Support Programs
Market Analysis
A sample report on
www.insights10.com
Includes Market Size, Market Segmented by Types
and Key Competitors (Data forecasts from 2021 – 2030F)

2. This report presents a strategic analysis of the Global Patient Support
Program market and a forecast for its development in the medium and
long term. It provides a comprehensive overview of the market value,
dynamics, segmentation, characteristics, main players, trends and insights,
growth and demand drivers, challenges & future outlook, etc. This is one of
the most comprehensive reports about the Global Patient Support Program
market, and offers unmatched value, accuracy, and expert insights

3. Table of
Contents
• Introduction
• Market Overview
• Growth Drivers & Restraints
• Market Segmentation
• Major Market Share
• Competitive Landscape
• Pharma Companies Sponsored PSPs
• Healthcare Policies & Regulatory Framework
• Factors Driving Future Growth
• Conclusion

4. 4 A Sample Report on Global Patient Support Program Market I Confidential
Table of Contents
1. Introduction…………………………………………………………………………………….………………………………..…………..7
1.1 Need for Patient Services
1.2 Patient support programs: What do they offer?
1.3 Various Patient Services
1.3.1 Caregiver Access
1.3.2 Healthcare Financing
1.3.3 Self Care/Compliance
1.4 Strong Desire for Support Services from Pharma Manufacturers
2. Global Patient Support Program Market Overview………………..……..…………………………………...................................15
2.1 Market size and forecast
3. Market Growth Drivers and Restraints….………………………………………………………………….…………….…………….17
3.1 Market Growth Drivers
3.1.1 Greater focus on Value and Outcomes
3.1.2 Growth in availability of Health Data
3.1.3 Shift from Reactive to Proactive Consumer
3.1.4 Rise of Personalized Medicine
3.2 Market Restraints

5. 5 A Sample Report on Global Patient Support Program Market I Confidential
Table of Contents (continued)
3.2.1 Siloed and Uncoordinated communications
3.2.2 Lack of Data Governance
3.2.3 Challenge of Program Management
3.2.4 Cost Ambiguity
4. Market Segmentation……………………………………………………………….…………………..…………………..………….….24
4.1 By Caregiver Access
4.2 By Healthcare Financing
5. Major Products Market Share………………………..…………………………………………………………………..…………....…28
5.1 Market Analysis, Insights and Forecast - By Revenue
6. Competitive Landscape……………………………………………………..……………………...…………..…................................30
6.1 Major companies for global market
7. Pharma companies sponsored PSP Programs…………………………………………………………...………………..…….......32
7.1 Connect360 (AstraZeneca)
7.2 Amgen Assist 360 (Amgen)
7.3 BMS Access Support (Bristol Myers Squibb)
7.4 Lilly Cares (Eli Lilly)

6. 6 A Sample Report on Global Patient Support Program Market I Confidential
Table of Contents (continued)
8. Healthcare Policies and Regulatory Landscape…………………………………………………….……………………..………....37
8.1 Regulatory framework of global patient support program market
9. Factors Driving Future Growth………………………………………………………………………………………………..………....39
9.1 Recent developments in patient support program
10. Strategic Recommendation……………………..…………..………………………………….……………………………………….41

7. Global Patient Support Program Market Analysis
1. Introduction

8. 8 A Sample Report on Global Patient Support Program Market I Confidential
People experience various difficulties around starting their medications and continuing to take them as prescribed, leading
to suboptimal behaviors that result in non-adherence
▪ Medication adherence is one of healthcare’s greatest and most costly challenges
▪ Non-adherence is estimated to cause approximately xx deaths in the US annually, costing the US health care
system up to $xx Bn/ year
▪ It is a nuanced and multi-factorial challenge, and patients’ needs while on treatment are highly differentiated
More serious the health condition of a patient, the more
Many patients want to receive support via phone. However, various digital channels like
1.1 Need for Patient Services

9. 9 A Sample Report on Global Patient Support Program Market I Confidential
Patient Support Programs (PSPs)
Patient Access Programs
Named Patient
Programs (NPP)
Financial
Assistance
Programs
Patient Adherence Programs
Loyalty Programs
Patient Education
Programs
Convenience Programs
Other Support
Programs
1.2 Patient Support Programs: What do they offer?

10. 10 A Sample Report on Global Patient Support Program Market I Confidential
Caregiver Access
Virtual Care/
Telehealth
Remote Monitoring
Self Care/ Compliance
Patient Education/
discovery
Medication delivery /
support
Healthcare Financing
Benefit Coverage
(BI/PA/Appeal)
Co-pay assistance
1.3 Various Patient Services

11. 11 A Sample Report on Global Patient Support Program Market I Confidential
1.3.1 Caregiver Access – (1/2)
Remote Monitoring
Remote patient monitoring enables monitoring of patients outside conventional clinical settings
thereby increasing access to care and reducing healthcare delivery costs
Virtual Care/
Telehealth
Platform enabling remote delivery of healthcare services
Companies in the space
Companies in the space
Companies in the space

12. 12 A Sample Report on Global Patient Support Program Market I Confidential
1.3.2 Healthcare Financing – (1/3)
Real Time Benefits
Verification
Providers need visibility into patient benefits to determine patient’s needs. RTBV technologies
integrate this information into provider workflows to improve care planning
Electronic Prior
Authorization (ePA)
ePA is the electronic transmission of information between the prescriber, and payer to determine
whether or not the PA is granted
Companies in the space
Companies in the space
Companies in the space

13. 13 A Sample Report on Global Patient Support Program Market I Confidential
1.3.3 Self Care / Compliance
Medication Delivery
Services enabling timely delivery of prescriptions at patients doorstep/ convenient location to
drive long term adherence through convenience
Patient Education Tools and platform that enables healthcare professionals and physicians to impart information and
knowledge to patients thereby altering their health behaviors and improving health outcomes
Companies in the space
Companies in the space
Companies in the space

14. 14 A Sample Report on Global Patient Support Program Market I Confidential
1.4 Strong Desire for Support Services from Pharma Manufacturers
Survey of more than 1,000 patients with chronic / complex conditions was conducted to evaluate the patient experience on
therapy: commonly encountered challenges related to access and adherence, support used, preferred, and expectations from
the manufacturer of the medications
xx% people wanted companion to talk to about their
medication and emotional concerns while dealing with
disease and treatment
xx% respondents needed financial and copay support
xx% respondents wanted services for frequent
medication reminders
xx% said increased communications from a physician
or nurse would be most beneficial
xx% said calls/visits from a nurse who is an expert in
the medication the patient is on would be most helpful
xx% of cancer and xx% of lupus patients agreed to
opting patient support services
xx% of respondents believe that pharma companies
should offer patient support services
xx% of those with complex or chronic conditions say
that they would opt in for patient support services
xx% were aware of the patient support services that are
currently offered by drug manufacturers, despite its high
demand
xx% actually reported utilization of pharma-provided
services

15. Global Patient Support Program Market Analysis
2. Overview

16. 16 A Sample Report on Global Patient Support Program Market I Confidential
Key Analysis
Global Patient Support Program Market Size $Bn
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
2.1 Market Size and Forecast
xx%
Patients believe that pharma companies should be
working more closely with
xx% Healthcare professionals are very aware of
xx%
Patients are aware of the services that pharmaceutical
companies
Patients believe pharmaceutical companies have a
responsibility
xx%
Pharma companies are raising their investment in
xx%
5.1

17. Global Patient Support Program Market Analysis
3. Growth Drivers & Restraints

18. 18 A Sample Report on Global Patient Support Program Market I Confidential
Greater Focus on Value
and Outcomes
Shift from Reactive
to Proactive Consumer
Lack of Data Governance
Siloed and Uncoordinated
communications
Impact
Impact
Market
Drivers
Market
Restraints
Growth in Availability of
Health Data
Market growth drivers and restraints
Rise of Personalized
Medicine
Challenge of Program
Measurement
Cost Ambiguity

19. 19 A Sample Report on Global Patient Support Program Market I Confidential
3.1.1 Greater Focus on Value and Outcomes
▪ Life sciences organizations are under pressure to justify their pricing and to demonstrate that their drugs can
improve treatment outcomes
3.1 Market growth drivers

20. 20 A Sample Report on Global Patient Support Program Market I Confidential
3.1 Market growth drivers (continued)
3.1.2 Growth in Availability of Health Data
▪ Sources like electronic medical records, claims and billing information, big data from wearables or social media
helps companies understand the quality, efficiency and safety of their treatments

21. 21 A Sample Report on Global Patient Support Program Market I Confidential
3.1 Market growth drivers (continued)
3.1.3 Shift from Reactive to Proactive Consumer
▪ Patients today take a more active role in managing their own health

22. 22 A Sample Report on Global Patient Support Program Market I Confidential
3.1 Market growth drivers (continued)
3.1.4 Rise of Personalized Medicine
▪ With growth of specialty drugs and personalized therapies, demand for individualized treatments is increasing

23. 23 A Sample Report on Global Patient Support Program Market I Confidential
3.2.1 Siloed and Uncoordinated
communications
3.2 Market restraints
▪ Patient services programs typically are executed
by multiple departments for multiple brands
utilizing both internal teams and external
partners leading to…..
3.2.2 Lack of Data Governance
▪ Patient services data is often unstructured and
lacking when it comes to data governance and
stewardship…..
3.2.3 Challenge of Program Measurement 3.2.4 Cost Ambiguity
▪ Measuring patient services program
effectiveness is often unstructured and lacks
clear success criteria, manufacturers will
utilize…..
▪ Generally, cost prediction is done at the
aggregate level for multiple programs and in
annual buckets, and there is no clear…..

24. Global Patient Support Program Market Analysis
4. Market Segmentation

25. 25 A Sample Report on Global Patient Support Program Market I Confidential
Patient Support Program Market Segmentation
Global Patient Support Program Market Segmentation
Caregiver Access
Healthcare at Home
Patient Transportation
Remote Monitoring
Virtual Care/ Telehealth
Health Coaching
Healthcare Financing
Alternative Coverage / PAPs
Benefit Coverage (BI/PA/Appeal)
Co-pay assistance
Reimbursement Support

26. 26 A Sample Report on Global Patient Support Program Market I Confidential
▪ Remote patient monitoring enables monitoring of patients
outside conventional clinical settings thereby increasing
access to care and reducing healthcare delivery costs
▪ Home healthcare is a supportive care provided by medical
professionals at patient’s home for the purpose of
promoting, maintaining or restoring health or maximizing
the level of independence while minimizing the effects of
disability and illness
4.1 Market Segmentation: By Caregiver Access
Patient Support Program Market Share by Caregiver Access
(2021)
Virtual Care/
Telehealth
Remote
Monitoring
Healthcare at
Home
Patient
Transportation
Health
Coaching
Key Insights

27. 27 A Sample Report on Global Patient Support Program Market I Confidential
▪ Electronic Prior Authorization (ePA)- it is the electronic
transmission of information between the prescriber, and
payer to determine whether or not the PA is granted
▪ Reimbursement Support - Services remove barriers to
successful payment of claims and provide a resource for
patients with coverage-related questions
4.2 Market Segmentation: By Healthcare Financing
Benefit Coverage
(BI/PA/Appeal)
Co-pay
Assistance
Alternative
Coverage / PAPs
Reimbursement
Support
Patient Support Program Market Share by Healthcare Financing
(2021)
Key Insights

28. Global Patient Support Program Market Analysis
5. Major Market Share

29. 29 A Sample Report on Global Patient Support Program Market I Confidential
5.1 Major Patient Support Program Market Share
Key Insights
▪ From the pharmaceutical company’s perspective, PSPs contribute to better patient outcomes overall, and as the industry shifts
more toward outcomes-based payment models, enhancing actual patient outcomes will be a crucial success element
▪ A strong patient support program will influence the approval of treatments and market authorizations and will boost patient
enrollment

30. Global Patient Support Program Market Analysis
6. Competitive Landscape

31. 31 A Sample Report on Global Patient Support Program Market I Confidential
6.1 Major players revenue (current and forecast)
Major Market Revenue of Patient Support Services
Companies ($Bn)
AstraZeneca
(Access 360)
Amgen (Assist
360)
Bristol Myers
Squibb (Access
Support)
Eli Lilly (Lilly
Cares)
Revenue share used for PSP Other revenue
SAMPLE
Key Insights

32. Global Patient Support Program Market Analysis
7. Pharma companies sponsored PSP Programs

33. 33 A Sample Report on Global Patient Support Program Market I Confidential
7.1 Connect360 (AstraZeneca)
▪ The AstraZeneca Patient Support Programs help patients
navigate the complexities of reimbursement and provide
support during the journey of their treatment
▪ Connect360, AstraZeneca Oncology patient support programs
are some of the PSPs going on currently
Company Name: AstraZeneca
Year of Establishment: 1999
Headquarter: Cambridge, US
Revenue: $37.4 Bn (2021)
Website: www.astrazeneca.com
Company at a Glance
Respective PSP Overview

34. 34 A Sample Report on Global Patient Support Program Market I Confidential
7.2 Amgen Assist 360 (Amgen)
▪ In 2019, the Amgen Safety Net Foundation provided nearly
$1.5 billion worth of our medicines to qualified uninsured or
underinsured patients in the U.S. at no cost -and Early $7
billion of our medicines since 2008
▪ Amgen Assist 360 provides financial support options for any
insurance type and referrals to resources for day-to-day living
Company Name: Amgen
Year of Establishment: 1980
Headquarter: Cambridge, US
Revenue: $26 Bn (2021)
Website: www.amgen.com
Company at a Glance
Respective PSP Overview

35. 35 A Sample Report on Global Patient Support Program Market I Confidential
7.3 BMS Access Support (Bristol Myers Squibb)
▪ Bristol Myers Squibb is committed to helping appropriate
patients get access to our medications by providing access
and reimbursement support services`
▪ BMS Access Support® is focused on your patients’ access
needs benefits Review, prior authorization, and appeals
assistance, easy-to-initiate co-pay assistance process and
information on financial support and support from Patient
Access Specialists, assigned by region, and local Access and
Reimbursement Managers
Company Name: Bristol Myers Squibb
Year of Establishment: 1887
Headquarter: New York, US
Revenue: $46.4 Bn (2021)
Website: www.bms.com
Company at a Glance
Respective PSP Overview

36. 36 A Sample Report on Global Patient Support Program Market I Confidential
7.4 Lilly Cares (Eli Lilly)
▪ Lilly Cares Foundation, Inc. (Lilly Cares) is a nonprofit
charitable organization that provides prescribed Lilly
medications for free for up to 12 months to qualifying U.S.
patients
▪ Over the past 20 years, Lilly Cares has helped more than one
million patients with financial need receive medicines donated
by Lilly
Company Name: Eli Lilly
Year of Establishment: 1876
Headquarter: Indiana, US
Revenue: $28.3 Bn (2021)
Website: www.lilly.com
Company at a Glance
Respective PSP Overview

37. Global Patient Support Program Market Analysis
8. Healthcare Policy and Regulatory Landscape

38. 38 A Sample Report on Global Patient Support Program Market I Confidential
8.1 Regulatory framework of global patient support program market
▪ Many countries, regions, and industry groups have local regulations that directly address (and often restrict) these
programs. For example, Canada, the UK and Australia have industry codes specifically addressing PSPs and, in
some cases, patient safety and data requirements or interactions with healthcare professionals (HCPs) and patients
in connection with PSPs
▪ Reimbursement of patient support program is done by various ways like bridging drugs (temporary or limited supply
of drug directly to a patient, provider, or institution), financial assistance (Payment on part of the drug cost; Payment
may be based on applicant’s; income and family size; Payment may be given to someone with or without coverage in
place) and compassionate drugs (temporary or long-term supply of drug to person in unique clinical situation)

39. Global Patient Support Program Market Analysis
9. Future Development Growth

40. 40 A Sample Report on Global Patient Support Program Market I Confidential
9.1 Recent developments in patient support program
▪ AI, machine learning and natural language processing tools can identify both clinical and socioeconomic data points
to ensure patient support teams are spending time with the right patients, particularly with those who may be closer
to non-adherence
▪ Pharma manufacturers often use training materials to create awareness for these programs, a channel growing in
popularity is actively participating in the patient journey — more specifically, connectivity with electronic health
records (EHRs) systems to augment education. These integrations builds improved awareness for providers,
growing program adoption

41. Global Patient Support Program Market Analysis
10. Conclusion

42. 42 A Sample Report on Global Patient Support Program Market I Confidential
Strategic Recommendations
1
2
3
5
4
Strong Demand
With the implementation of
government norms
towards…..
Emerging Initiative
Ease in regulations by the
government and
collaborations between…..
Growing Technology
Advancements
With the emerging
technology and the
transformation from…..
Support for the HCPs
Patient support programs are
also assisting HCPs to
deliver…..
Advancement in healthcare
delivery
PSPs would enhance the
way healthcare was delivered
to the patient earlier, with…..

43. Methodology & Scope

44. 44 A Sample Report on Global Patient Support Program Market I Confidential
▪ Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the
key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive
overview of the competitive landscape to help our clients make informed strategic decisions
▪ We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial
phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government
and regulatory published material, technical journals, trade magazines, and paid data sources
▪ For forecasting, the following parameters are considered:
❑ Market drivers and restraints along with their current and expected impacts
❑ Technological scenario and expected developments
❑ End use industry trends and dynamics
❑ Trends in the consumer behavior
❑ Regulatory scenario and expected developments
❑ Current capacity and expected capacity additions up to 2030
▪ In our report we have assigned weights to the US specific parameters and quantified the market impacts. Which similarly, could be
useful in identifying the global scenario
▪ We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-
sensitive, reflecting the most recent value and volume of the market across regions
▪ All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪ The currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion
Research methodology

45. 45 A Sample Report on Global Patient Support Program Market I Confidential
Our Analysis Methodology involves three critical stages:
Primary
Research
Secondary
Research
Market Trends
Market Sizing &
Analysis
Data Triangulation &
Validation
Analysis &
Interpretation
Insights
Presentation &
Reporting
Data Collection
Market Data Analysis
& Statistical Model
Interpretation and
Presentation
Analysis methodology

46. 46 A Sample Report on Global Patient Support Program Market I Confidential
Bottom Up Approach
Summarization of revenue
generated from companies
to arrive at total market size
Revenue generated by products &
services offered by companies
Validation from
Primary Interview
Final
Market
Size
Top Down Approach
Final Market size break up to
rest of segmentation
Arriving at market size
of each segment
Validation from
Primary Interview
Final
Summary
Data triangulation and data validation

47. 47 A Sample Report on Global Patient Support Program Market I Confidential
The study provides an in-depth analysis of the Global Patient Support Program market with current trends and future
estimations to elucidate the imminent investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and
quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided
Comprehensive quantitative analysis of the industry from 2021 to 2030F is provided to enable the stakeholders to capitalize on
the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally
Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater
understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors
Key benefits for stakeholders from this report

48. 2021
2022-
2030
Report Attribute
Quantitative Units
Report Coverage
Customized Report
Pricing and purchase
options
Revenue in USD Million/Billion (Mn/Bn)
Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities
Report Customization (5 working days) with
purchase. We will provide you with data that is
currently not a part of our scope as a part of
customization
Avail customized purchase options to meet
your exact research needs
Details
Time Frame
Base Year for
Estimation
Forecast
Period

49. The report is prepared
using a proven
methodology and
insightful research
Reliable
The data is prepared by
a team of highly qualified
& experienced research
analysts & vetted by our
local associates
Expert-verified
Allowing you to
confidently make
smarter business
and strategic
decisions
Real
Covers everything you
would need to know
about the market
including market size,
competitive analysis &
much more
Comprehensive
You do not have to be a
market expert to
understand what really is
happening on the market
and how it works
Easy to read
What kind of Data is Presented
in this Report?
This report presents data, which is:
www.insights10.com

50. About

51. www.insights10.com
A large database of over 30,000 syndicated market
research reports in pharmaceuticals and
healthcare sector at global, regional as well as
country level. We also provide customized
research reports tailor made to suit your needs
Lifesciences Market
Research Reports you
can trust

52. Insights10 is a healthcare focused market
research firm founded with an aim of being an
insights driven company in the data driven world
and delivering actionable insights that can drive
decision and strategy making process for
businesses
Get Insights to take
informed Business
Decisions
www.insights10.com

53. Market Research Reports
across various domains of healthcare
Healthcare
Services
Clinical
Trials
OTC &
Nutraceuticals
Pharmaceuticals
(Diseases & Drugs)
Digital
Health
Medical
Devices

54. Our
Services
1
2
3
4
5
6
10
9
8
7
Market Research Reports
Customized Reports
Primary Research
Database Services
Full-Time Engagement
Conference Coverage
Competitive Intelligence
Strategic Research Projects Regulatory Compliance
Report Subscription Services

55. Our Research Process
01 03
02 04 05
Identification of
Data
Collection of
Data
Market
Dynamics
Collaboration
of Data
Verification &
Analysis
www.insights10.com

56. Statistical Databases
Data
Sources
We have access to multiple highly
reliable free and subscription data
sources. We have many years of
experience to understand which
sources are more dependable for what
and which to prefer for the reliable and
latest information.
Company Websites/Annual Reports
Trade Publications
Online Databases
Published Research Reports
Whitepapers
Press Releases of Key Market Players
www.insights10.com

57. Research Projects Done
Over the years, we have developed an in-depth experience of executing
market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Africa and
Asia Pacific regions

58. Mukesh is an engineering graduate
with an MBA in Marketing. He is a
seasoned healthcare market
research & marketing professional
with a progressive experience of over
20 years in Life Sciences, Pharma
and Medical Device sectors . With an
in-depth understanding of primary
research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare
& completed several research
projects across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across
diff. markets (America, Europe, Africa,
APAC and Middle East). Her areas of
expertise include: Indentifying emerging
trends in life sciences industry,
Competitor landscape assessment,
Disease opportunity assessments etc.
She is a pro in secondary and primary
research with a deep domain expertise
in healthcare sector.
Purav is a physician and an
entrepreneur with 12+ years of
experience in Healthcare & Life
Sciences industry spanning across
strategy, market access, health
informatics and RWE, digital health,
analytics and data science. Purav
studied medicine from Gujarat
University and also completed his MBA
from IIM-Kozhikode. Purav started his
career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Dhruv Joshi is an engineer and has done
Masters in Hospital Administration with
over 4 years of experience in the
healthcare and life science industry. He
has gained proficiency in market
research, market assessment, and
developing insights from it. He has
worked on various consulting projects
across different geographies including
Asia, Europe, US, MENA. He has been
aligned in working for sector reports of
various geographies along with market
sizing and forecasting.
Dr. Purav Gandhi
Founder & CEO
Mukesh Nayak
Head - Marketing
Ritu Baliya
Engagement Manager
Dhruv Joshi
Consultant
Project Leadership Team

59. 7 years of experience working with leading organizations in pharma, MedTech
and healthcare domain. Some of our recent clients are mentioned below
… and many more

60. Web: www.insights10.com
Email: insights@insights10.com
Call: (+91) 931 639 7935
Whatsapp: (+91) 931 639 7935
We would be happy to help.